{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:50:05Z","timestamp":1777675805217,"version":"3.51.4"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,4,10]],"date-time":"2005-04-10T00:00:00Z","timestamp":1113091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Growth hormone deficiency (GHD) secondary to cranio\u2010spinal radiation therapy (CSRT) is a complication seen in medulloblastoma survivors. The standard for diagnosis of adult GHD is a peak GH &lt;\u00a03\u00a0\u00b5g\/l by the insulin tolerance test (ITT). However, insulin tolerance testing exposes patients to the risks of hypoglycaemia. Recent studies suggest that the GH releasing hormone\u00a0+\u00a0arginine (GHRH\u00a0+\u00a0ARG) test can identify GHD in cranially irradiated patients at longer time intervals after radiation. We evaluated the GHRH\u00a0+ ARG stimulation test compared to the ITT in young adults diagnosed with medulloblastoma during childhood.<\/jats:p><jats:p><jats:bold>Patients\u2002<\/jats:bold> We evaluated 10 young adult patients (age range 17\u201326\u00a0years) who were treated with CSRT during childhood for medulloblastoma, and who had resultant childhood\u2010onset GHD.<\/jats:p><jats:p><jats:bold>Measurements\u2002<\/jats:bold> Subjects underwent GH provocative testing with the ITT and the GHRH\u00a0+\u00a0ARG test. IGF\u2010I and IGFBP3 levels were also measured at baseline.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Insulin tolerance testing and GHRH\u00a0+\u00a0arginine stimulation were performed at a mean\u00a0\u00b1\u00a0SD 14\u00a0\u00b1\u00a04\u00b74\u00a0years after cranial radiation. All patients failed the ITT with median peak GH 0\u00b740\u00a0\u00b5g\/l (range &lt;\u00a00\u00b705\u20132\u00b72). GHRH\u00a0+\u00a0arginine gave higher peak GH levels with a mean of 7\u00b79\u00a0\u00b1\u00a05\u00b77\u00a0\u00b5g\/l (<jats:italic>P\u00a0=<\/jats:italic>\u00a00\u00b7003). Four patients had peak GH\u00a0&gt;\u00a09\u00a0\u00b5g\/l and were between 7\u00b78 and 19\u00b76\u00a0years from cranial radiation. There was no correlation of peak GH levels with time interval since CSRT. Thirty\u2010three per cent of subjects had normal IGF\u2010I; neither IGF\u2010I nor IGFBP3 standard deviation scores (SDS) correlated with ITT results.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Using a GHRH\u00a0+\u00a0arginine cut\u2010off for GHD of 9\u00a0\u00b5g\/l, four patients would have been misclassified as GH sufficient, despite being &gt;\u00a07\u00a0years (with two patients being nearly 20\u00a0years) out from CSRT. These findings suggest that the pituitary GH\u2010producing cells of young adults continue to maintain responsiveness to GHRH\u00a0+ arginine more than 5\u201310\u00a0years after cranial irradiation.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02272.x","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T10:09:33Z","timestamp":1114078173000},"page":"628-632","source":"Crossref","is-referenced-by-count":33,"title":["Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio\u2010spinal radiation therapy"],"prefix":"10.1111","volume":"62","author":[{"given":"J. Nina","family":"Ham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill P.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine D.","family":"Hendell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Thomas","family":"Moshang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of GH replacement: a review","volume":"83","author":"Carroll P.V.","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.379"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8509"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-6-1186"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00923.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.5.1615"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1340352"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021094"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.11.3990"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.10.3693"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1060281"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb03548.x"},{"key":"e_1_2_6_14_2","first-page":"131","article-title":"Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy","volume":"6","author":"Jorgensen E.V.","year":"1993","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02525.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.6.717"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-2-503"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000053232"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023237"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00804.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.8056"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02272.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02272.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:03:11Z","timestamp":1697187791000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02272.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02272.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02272.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,10]]}}}